Description
This department provides decision tools to help decision-makers in their choice between different health strategies related to drugs, medical devices, or diagnostic tests. The interdisciplinary team helps manufacturers collect the relevant clinical and health economic data for obtaining a fair price and reimbursement for their innovation in major European markets.
We also support manufacturers in communicating the value of new products to multiple stakeholders, though an all-encompassing view of clinical efficacy, real-world data, and opportunity costs of various intervention mixes, budget impact, and cost-effectiveness models.
Our solutions
Pricing & Reimbursement
Submissions to HTA agencies
Clinical evidence vs. Economic Models
Budget impact analysis
Analytic modelling & decision-making
Micro-costing analyses
Handling of national databases
Systematic review and meta-analyses
Day-to-day activity
Pricing & Reimbursement dossiers
Submissions to HTA agencies
Modeling (Markov, Microsimulation, DES, etc.)
Multi-Criteria Decision-Analysis, Decision Tree Analysis, etc.
Database handling (PMSI, NHS, etc.)
Network meta-analysis